U.S. Physical Therapy, Inc. (NYSE:USPH) Given Average Rating of “Moderate Buy” by Analysts

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have earned an average recommendation of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $110.25.

Several research analysts have issued reports on USPH shares. Zacks Research raised U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Barrington Research lifted their price objective on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a research report on Friday, August 8th. Finally, Wall Street Zen raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th.

Insider Buying and Selling

In other news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the transaction, the director owned 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Graham D. Reeve sold 1,792 shares of the business’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $86.57, for a total value of $155,133.44. Following the transaction, the chief operating officer owned 22,246 shares of the company’s stock, valued at approximately $1,925,836.22. The trade was a 7.45% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 2,955 shares of company stock valued at $251,170. Company insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of U.S. Physical Therapy by 952.4% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company’s stock worth $32,000 after buying an additional 400 shares during the last quarter. Parallel Advisors LLC boosted its stake in shares of U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock worth $35,000 after buying an additional 213 shares during the last quarter. Cullen Frost Bankers Inc. boosted its stake in shares of U.S. Physical Therapy by 171.8% in the second quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock worth $35,000 after buying an additional 280 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter worth about $39,000. Finally, Assetmark Inc. boosted its stake in shares of U.S. Physical Therapy by 35.7% in the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after buying an additional 150 shares during the last quarter.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock opened at $87.5170 on Monday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30. The company has a market cap of $1.33 billion, a PE ratio of 38.22, a P/E/G ratio of 4.47 and a beta of 1.45. The business has a 50 day moving average of $78.26 and a 200 day moving average of $76.75. U.S. Physical Therapy has a 52 week low of $62.77 and a 52 week high of $101.19.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The firm had revenue of $197.34 million during the quarter, compared to the consensus estimate of $190.24 million. During the same period last year, the company earned $0.73 earnings per share. The company’s revenue was up 18.0% on a year-over-year basis. As a group, equities research analysts forecast that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be paid a $0.45 dividend. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a yield of 2.1%. U.S. Physical Therapy’s payout ratio is presently 78.60%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.